Daniel Kaye Buys Shares of CME Group
Daniel Kaye bought 645 shares of CME Group for $145,125 on June 25, 2026.
Key Points
- Daniel Kaye purchased 645 shares of CME Group Inc. for $145,125 on June 25, 2026, at $225 each.
- CME Group has a market cap of $79.85 billion, a P/E ratio of 18.87, and a 52-week range of $220.73 to $329.16.
- Analysts like Rothschild & Co upgraded the stock to 'buy' with a price target of $323 on June 11, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 25, 2026, Daniel Kaye purchased 645 shares of CME Group Inc. (NasdaqGS: CME), investing $145,125 at an average price of $225 per share. This insider transaction wasn't planned under a Rule 10b5-1 trading plan.
Insider Buying and Selling at CME Group Inc.
Daniel Kaye's recent purchase is part of a series of insider buys at CME Group. On the same day, insiders like Phyllis Lockett, Howard Siegel, William Shepard, Rahael Seifu, Bryan Durkin, and Patrick Maloney each bought shares at the same price of $225, reflecting confidence in the company.
Other Institutional Activity in CME Group
In the institutional landscape, BlackRock, Inc. increased its holdings by 370,381 shares, bringing its total to 31,448,257 shares valued at approximately $9.29 billion. Vanguard Capital Management LLC opened a new position, acquiring 23,367,282 shares worth about $6.90 billion. Meanwhile, State Street Corp reduced its stake by 89,238 shares to 16,055,287, valued at $4.74 billion. JPMorgan Chase & Co added 1,108,304 shares, totaling 12,209,761 shares worth around $3.63 billion. Morgan Stanley also grew its position by 1,043,692 shares, holding 9,406,843 shares valued at $2.78 billion.
CME Group Inc. Stock Down 22.7%
On Tuesday, shares of CME Group Inc. traded near $221. The company boasts a market cap of $79.85 billion, a P/E ratio of 18.87, and a beta of 0.244, indicating relatively low volatility. Its 52-week range spans from $220.73 to $329.16, with a 50-day moving average of $273.98 and a 200-day moving average of $280.89. The firm's current ratio stands at 1.018, with a quick ratio of 0.021 and a debt-to-equity ratio of 14.059.
$CME stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
CME Group reported revenue of $6.74 billion, reflecting a growth of 14.4%. The company achieved a net margin of 63.32% and a return on equity of 15.92%. With an EPS of $11.71, CME Group is set to announce its next earnings on July 22, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target cuts vs 0 raises.
-
EPS & revenue
EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.
-
Profit surprise
EBITDA missed by 6 percent. Operating income missed by 5 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
2 target cuts.
-
Earnings quality
Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.
Earnings Call Summary
CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.
Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.
Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.
Dividend
CME Group offers an attractive dividend rate of $5.20, yielding 2.35%, with a payout ratio of 95.56%.
Analysts Set New Price Targets
On June 11, 2026, Rothschild & Co upgraded CME Group to a 'buy' rating with a price target of $323. Morgan Stanley maintained its 'buy' rating with a target of $353. The consensus among 15 analysts is a 'buy' recommendation, with an average price target of $302.60.
About CME Group
CME Group Inc., headquartered in Chicago, Illinois, operates global markets for trading futures and options. It provides a range of products, including futures on interest rates, equity indexes, and foreign exchange, as well as commodities like agriculture, energy, and metals. The company also offers clearing services and market data services to a wide array of clients, including traders, financial institutions, and governments.
Bottom Line
Daniel Kaye's purchase of CME Group shares highlights insider confidence in the company. With a robust market presence and a solid financial standing, CME Group remains a key player in the financial services sector. Investors often monitor insider transactions for potential insights, though it's important to remember these reports are retrospective.
Get CME Group Inc. alerts
New 13F filings, insider trades, and analyst moves on $CME, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.